No Results
"We are currently gathering more data to assess the safety of genentech-access.com. Your safety is our priority, and we're conducting a thorough analysis before providing a comprehensive evaluation."
Learn about Genentech Access Solutions, a resource that provides reliable, effective access and reimbursement support to assist your patients and practice.
Traffic rank of genentech-access.com, compared to all other sites
↓ 1.14M+
United States
Website ranking is crucial for evaluating genentech-access.com's stats. TopWeb.ai leverages cutting-edge techniques, including data gathering, collection, and analysis from diverse internet resources, to estimate website traffic. Our assessments are based solely on publicly available information, offering valuable insights into potential traffic trends without relying on business owner-provided data. Additionally, we utilize advanced tools like ChatGPT and Gemini API to enhance our evaluation process, ensuring accurate and comprehensive traffic estimations and analysis.
Over the last three months, genentech-access.com's global ranking has decreased from 94,246 to 1,235,916.
Total Visits
Bounce Rate
Pages per Visit
Avg Visit Duration
Moz metrics are by Moz that predicts how well a specific page will rank.
WOT's security score derives from our partners and community-driven expert reviews
Amazon Alexa Rank provides a broad gauge of a website's online popularity.
The Organic Search section reveals valuable insights, including organic traffic and keywords for in Google's top 100 search results.
Explore alternative, competitive and similar websites to genentech-access.com based on traffic, content and site structure.
Breakthrough science. One moment, one day, one person at a time.
Gene alternatives
Learn about OCREVUS® (ocrelizumab), a prescription medicine used to treat adults with relapsing or primary progressive multiple sclerosis. See full safety for more information.
Ocrevus alternatives
XOLAIR (omalizumab) for subcutaneous use is a prescription treatment for moderate to severe persistent allergic asthma not controlled with ICS and chronic idiopathic urticaria (CIU) in appropriate patients. See full safety & Boxed Warning
Xolair alternatives
Learn about XOLAIR (omalizumab) as a treatment for Allergic Asthma patients uncontrolled on inhaled corticosteroids and chronic idiopathic urticaria (CIU) patients. See full safety & Boxed Warning
Xolairhcp alternatives
Cortizone 10 Anti-Itch Products
Cortizone10 alternatives
MIMS online, search the database of prescription and generic drugs, clinical guidelines and patient advice.
Mims alternatives
Medbase-apotheken alternatives
Cdncare alternatives
StaffReady healthcare software provides cloud-based solutions that automate staff scheduling, competency assessment, and document control for healthcare organizations. StaffReady is Clinical Workforce Management Software.
Staffready alternatives
Centrum alternatives
Check out some of our popular sites.